logo
Select company
Select metric
-99.49%EBIT Margin
VS
Market
13
Sector
38
Industry
25
History
56
$ 3.17Close
$ 2.08 - $ 6.95 52-Week Range
Ticker Information

Ticker

VVOS

Company Name

VIVOS THERAPEUTICS INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

VIVOS THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VVOS - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -14.32M-99.49%$ 14.39M
3/31/2025$ -11.24M-76.82%$ 14.63M
12/31/2024$ -11.14M-74.09%$ 15.03M
9/30/2024$ -12.57M-86.19%$ 14.58M
6/30/2024$ -12.04M-85.9%$ 14.02M
3/31/2024$ -15.64M-117.06%$ 13.36M
12/31/2023$ -13.58M-98.42%$ 13.8M
9/30/2023$ -15.41M-106.27%$ 14.5M
6/30/2023$ -18.75M-121.4%$ 15.45M
3/31/2023$ -20.22M-124.52%$ 16.24M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VIVOS THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at -93.18%.
  • Over the past 5 years, VIVOS THERAPEUTICS INC's average EBIT % has been -108.82%.
  • The median EBIT % for VIVOS THERAPEUTICS INC during this period was -106.27%
  • VIVOS THERAPEUTICS INC reached its highest EBIT % over the past 5 years at -74.09%.
  • The lowest EBIT % recorded by VIVOS THERAPEUTICS INC in the same timeframe -152.69%

VIVOS THERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
NMTC : NEUROONE MEDICAL TECHNOLOGIES CORP -55.42%XLO : XILIO THERAPEUTICS INC -374.79%NEPH : NEPHROS INC 8.1%ALUR : ALLURION TECHNOLOGIES INC -104.15%POCI : PRECISION OPTICS CORPORATION INC -29.08%COCH : ENVOY MEDICAL INC -8783.33%NXGL : NEXGEL INC -24.37%BCAB : BIOATLA INC -541.05%XAIR : BEYOND AIR INC -826.24%CRIS : CURIS INC -341.25%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for VIVOS THERAPEUTICS INC is calculated as follows: EBIT [ $ -10.62M ] / Revenues [ $ 11.39M ]
(=) EBIT % [ -93.18% ]

VVOS - EBIT Margin, Last 5 years

-152.69%

Minimum

Sep 30, 2022

-74.09%

Maximum

Dec 31, 2024

-108.82%

Average

-106.27%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.59% with a standard deviation of 23.91%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-72.99%
max83.08%
average9.59%
median9.02%
std23.91%